Company Filing History:
2 out of 2,405 
1 out of 97 
Years Active: 2010-2012
Title: The Innovations of Peter H Dobbelaar
Introduction
Peter H Dobbelaar is an accomplished inventor based in Morris Plains, NJ (US). He holds two patents that contribute significantly to the fields of medicine and pharmacology. His work focuses on developing novel compounds that target specific receptors in the human body, which can lead to advancements in treating various health conditions.
Latest Patents
One of his latest patents is titled "Substituted imidazoles as bombesin receptor subtype-3 modulators." This patent describes certain novel substituted imidazoles that act as ligands for the human bombesin receptor, particularly selective for the bombesin receptor subtype-3 (BRS-3). These compounds are promising for the treatment, control, or prevention of diseases and disorders that can be managed through BRS-3 modulation, such as obesity and diabetes.
Another significant patent is "Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators." This invention involves novel N-acylated spiropiperidine derivatives that serve as ligands for the human melanocortin receptor, specifically the melanocortin-4 receptor (MC-4R). These derivatives are useful for addressing various health issues, including obesity, diabetes, nicotine addiction, alcoholism, and sexual dysfunction.
Career Highlights
Peter has worked with notable companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and Albany Molecular Research, Inc. His experience in these organizations has allowed him to contribute to significant advancements in drug development and therapeutic solutions.
Collaborations
Throughout his career, Peter has collaborated with esteemed colleagues, including Shuwen He and Ravi P Nargund. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Peter H Dobbelaar's contributions to the field of pharmacology through his innovative patents highlight his commitment to addressing critical health challenges. His work continues to pave the way for new treatments that can improve the quality of life for many individuals.